Chinese artificial intelligence-powered drug researcher XtalPi Holdings said it expects to turn its first annual profit on the back of strong revenue growth, according to a corporate filing.
The Shenzhen-based company projected a swing to a net profit of at least 100 million yuan (US$14.5 million) in 2025 from a net loss of around 1.5 billion yuan in 2024, notching its first full-year profit, according to a filing with the Hong Kong stock exchange on Tuesday.
XtalPi attributed the earnings boost…
X begins testing standalone X Chat app on iOS
...
Read moreDetails
